help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stewart, P. M.
Right arrow Articles by Mason, J. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stewart, P. M.
Right arrow Articles by Mason, J. I.

Journal of Clinical Endocrinology & Metabolism, Vol 79, 480-484, Copyright © 1994 by Endocrine Society

ARTICLES

Human kidney 11 beta-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type I isoform

PM Stewart, BA Murry and JI Mason
Cecil H. and Ida Green Center for Reproductive Biology Sciences, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75235-9051.

11 beta-Hydroxysteroid dehydrogenase (11 beta HSD) catalyzes the conversion of cortisol to cortisone and plays an important role in the mammalian kidney in regulating cortisol access to the mineralocorticoid receptor. 11 beta HSD-deficient states, such as the syndrome of apparent mineralocorticoid excess (AME), and licorice ingestion result in hypertension in which cortisol acts as a mineralocorticoid. A gene and complementary DNA sequence encoding type I human 11 beta HSD have been described, but this gene is normal in patients with AME. Separate 11 beta HSD isoforms have been described in rat and rabbit kidney, but 11 beta HSD has not been characterized in human kidney. Kinetic analysis of 11 beta HSD activity in human fetal kidney microsomes revealed only a high affinity isoform (apparent Km, 60 nmol/L for cortisol, 13 nmol/L for corticosterone), the activity of which was exclusively nicotinamide adenine dinucleotide (NAD) dependent. No 11- oxo-reductase activity was seen in either renal homogenates or microsomes. 11 beta-Dehydrogenase activity was inhibited by glycyrrhetinic acid (the active ingredient in licorice) in a competitive fashion, with a Ki of 8.7 nmol/L. This 11 beta HSD isoform was clearly distinct from the type I h11 beta HSD enzyme, in that COS-1 cells transfected with type I h11 beta HSD complementary DNA expressed a low affinity (apparent Km, 2.13 mumol/L) isoform, the activity of which was NAD phosphate dependent. 11-Oxo-reductase activity was present in intact transfected cells (apparent Km for cortisone, 0.36 mumol/L), but not in cell lysates. In contrast to the cloned, low affinity, type I h11 beta HSD enzyme, human kidney contains a high affinity NAD-dependent 11 beta HSD isoform. It seems probable that this isoform is responsible for protecting the renal mineralocorticoid receptor from glucocorticoid excess, and a defect in its activity may explain AME.


This article has been cited by other articles:


Home page
 Eur J EndocrinolHome page
M. Debono, R. J Ross, and J. Newell-Price
Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy
Eur. J. Endocrinol., May 1, 2009; 160(5): 719 - 729.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. W. Tomlinson, M. Sherlock, B. Hughes, S. V. Hughes, F. Kilvington, W. Bartlett, R. Courtney, P. Rejto, W. Carley, and P. M. Stewart
Inhibition of 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Activity in Vivo Limits Glucocorticoid Exposure to Human Adipose Tissue and Decreases Lipolysis
J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 857 - 864.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
I. J Bujalska, O. M Durrani, J. Abbott, C. U Onyimba, P. Khosla, A. H Moosavi, T. T Q Reuser, P. M Stewart, J. W Tomlinson, E. A Walker, et al.
Characterisation of 11{beta}-hydroxysteroid dehydrogenase 1 in human orbital adipose tissue: a comparison with subcutaneous and omental fat
J. Endocrinol., February 1, 2007; 192(2): 279 - 288.
[Abstract] [Full Text] [PDF]

Home page
 ReproductionHome page
M Mandl, N Ghaffari-Tabrizi, J Haas, G Nohammer, and G Desoye
Differential glucocorticoid effects on proliferation and invasion of human trophoblast cell lines
Reproduction, July 1, 2006; 132(1): 159 - 167.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
N. Draper and P. M Stewart
11{beta}-Hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action
J. Endocrinol., August 1, 2005; 186(2): 251 - 271.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
H. Chisaka, J. F. Johnstone, M. Premyslova, Z. Manduch, and J. R.G. Challis
Effect of Pro-inflammatory Cytokines on Expression and Activity of 11{beta}-Hydroxysteroid Dehydrogenase Type 2 in Cultured Human Term Placental Trophoblast and Human Choriocarcinoma JEG-3 Cells
Reproductive Sciences, July 1, 2005; 12(5): 303 - 309.
[Abstract] [PDF]

Home page
 EndocrinologyHome page
K. N. Hewitt, E. A. Walker, and P. M. Stewart
Minireview: Hexose-6-Phosphate Dehydrogenase and Redox Control of 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Activity
Endocrinology, June 1, 2005; 146(6): 2539 - 2543.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Giavoli, R. Libe, S. Corbetta, E. Ferrante, A. Lania, M. Arosio, A. Spada, and P. Beck-Peccoz
Effect of Recombinant Human Growth Hormone (GH) Replacement on the Hypothalamic-Pituitary-Adrenal Axis in Adult GH-Deficient Patients
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5397 - 5401.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. W. Tomlinson, E. A. Walker, I. J. Bujalska, N. Draper, G. G. Lavery, M. S. Cooper, M. Hewison, and P. M. Stewart
11{beta}-Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid Response
Endocr. Rev., October 1, 2004; 25(5): 831 - 866.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. Lin-Su, P. Zhou, N. Arora, B. P. Betensky, M. I. New, and R. C. Wilson
In Vitro Expression Studies of a Novel Mutation {Delta}299 in a Patient Affected with Apparent Mineralocorticoid Excess
J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2024 - 2027.
[Abstract] [Full Text] [PDF]

Home page
 Recent Prog Horm ResHome page
J. R. Seckl, N. M. Morton, K. E. Chapman, and B. R. Walker
Glucocorticoids and 11beta-Hydroxysteroid Dehydrogenase in Adipose Tissue
Recent Prog. Horm. Res., January 1, 2004; 59(1): 359 - 393.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
N. Alfaidy, W. Li, T. MacIntosh, K. Yang, and J. Challis
Late Gestation Increase in 11{beta}-Hydroxysteroid Dehydrogenase 1 Expression in Human Fetal Membranes: A Novel Intrauterine Source of Cortisol
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 5033 - 5038.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Quinkler and P. M. Stewart
Hypertension and the Cortisol-Cortisone Shuttle
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2384 - 2392.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. Suzuki, K. Koyama, A. Darnel, H. Ishibashi, S. Kobayashi, H. Kubo, T. Suzuki, H. Sasano, and Z. S. Krozowski
Dexamethasone Upregulates 11{beta}-Hydroxysteroid Dehydrogenase Type 2 in BEAS-2B Cells
Am. J. Respir. Crit. Care Med., May 1, 2003; 167(9): 1244 - 1249.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
M. P. Hardy, C. M. Sottas, R. Ge, C. R. McKittrick, K. L. Tamashiro, B. S. McEwen, S. G. Haider, C. M. Markham, R. J. Blanchard, D. C. Blanchard, et al.
Trends of Reproductive Hormones in Male Rats During Psychosocial Stress: Role of Glucocorticoid Metabolism in Behavioral Dominance
Biol Reprod, December 1, 2002; 67(6): 1750 - 1755.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
I. J. Bujalska, E. A. Walker, M. Hewison, and P. M. Stewart
A Switch in Dehydrogenase to Reductase Activity of 11{beta}-Hydroxysteroid Dehydrogenase Type 1 upon Differentiation of Human Omental Adipose Stromal Cells
J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1205 - 1210.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
N. Alfaidy, Z. G. Xiong, L. Myatt, Stephen. J. Lye, J. F. MacDonald, and J. R. G. Challis
Prostaglandin F2{alpha} Potentiates Cortisol Production by Stimulating 11{beta}-Hydroxysteroid Dehydrogenase 1: A Novel Feedback Loop That May Contribute to Human Labor
J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5585 - 5592.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. L. McTernan, N. Draper, H. Nicholson, S. M. Chalder, P. Driver, M. Hewison, M. D. Kilby, and P. M. Stewart
Reduced Placental 11{beta}-Hydroxysteroid Dehydrogenase Type 2 mRNA Levels in Human Pregnancies Complicated by Intrauterine Growth Restriction: An Analysis of Possible Mechanisms
J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4979 - 4983.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. S. Moore, J. P. Monson, G. Kaltsas, P. Putignano, P. J. Wood, M. C. Sheppard, G. M. Besser, N. F. Taylor, and P. M. Stewart
Modulation of 11{beta}-Hydroxysteroid Dehydrogenase Isozymes by Growth Hormone and Insulin-Like Growth Factor: In Vivo and In Vitro Studies
J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4172 - 4177.
[Abstract] [Full Text]

Home page
 Arch. Dis. Child.Home page
D. V Milford
Investigation of hypertension and the recognition of monogenic hypertension
Arch. Dis. Child., November 1, 1999; 81(5): 452 - 455.
[Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
M. B. Feinstein and R. P. Schleimer
Regulation of the Action of Hydrocortisone in Airway Epithelial Cells by 11beta -Hydroxysteroid Dehydrogenase
Am. J. Respir. Cell Mol. Biol., September 1, 1999; 21(3): 403 - 408.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
I. J. Bujalska, S. Kumar, M. Hewison, and P. M. Stewart
Differentiation of Adipose Stromal Cells: The Roles of Glucocorticoids and 11{beta}-Hydroxysteroid Dehydrogenase
Endocrinology, July 1, 1999; 140(7): 3188 - 3196.
[Abstract] [Full Text]

Home page
 Biol. Reprod.Home page
J. Tremblay, D.B. Hardy, L.E. Pereira, and K. Yang
Retinoic Acid Stimulates the Expression of 11ß-Hydroxysteroid Dehydrogenase Type 2 in Human Choriocarcinoma JEG-3 Cells
Biol Reprod, March 1, 1999; 60(3): 541 - 545.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. A. Patel, K. Sun, and J. R. G. Challis
Local Modulation by 11{beta}-Hydroxysteroid Dehydrogenase of Glucocorticoid Effects on the Activity of 15-Hydroxyprostaglandin Dehydrogenase in Human Chorion and Placental Trophoblast Cells
J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 395 - 400.
[Abstract] [Full Text]

Home page
 Biol. Reprod.Home page
M. Tetsuka, M. Milne, G.E. Simpson, and S.G. Hillier
Expression of 11ß-Hydroxysteroid Dehydrogenase, Glucocorticoid Receptor, and Mineralocorticoid Receptor Genes in Rat Ovary
Biol Reprod, February 1, 1999; 60(2): 330 - 335.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. Condon, C. Gosden, D. Gardener, P. Nickson, M. Hewison, A. J. Howie, and P. M. Stewart
Expression of Type 2 11{beta}-Hydroxysteroid Dehydrogenase and Corticosteroid Hormone Receptors in Early Human Fetal Life
J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4490 - 4497.
[Abstract] [Full Text]

Home page
 HypertensionHome page
Y. Takeda, S. Inaba, K. Furukawa, and I. Miyamori
Renal 11ß-Hydroxysteroid Dehydrogenase in Genetically Salt-Sensitive Hypertensive Rats
Hypertension, December 1, 1998; 32(6): 1077 - 1082.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. L. Ricketts, J. M. Verhaeg, I. Bujalska, A. J. Howie, W. E. Rainey, and P. M. Stewart
Immunohistochemical Localization of Type 1 11{beta}-Hydroxysteroid Dehydrogenase in Human Tissues
J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1325 - 1335.
[Abstract] [Full Text]

Home page
 Cardiovasc ResHome page
S. H.M. van Uum, A. R.M.M. Hermus, P. Smits, T. Thien, and J. W.M. Lenders
The role of 11{beta}-hydroxysteroid dehydrogenase in the pathogenesis of hypertension
Cardiovasc Res, April 1, 1998; 38(1): 16 - 24.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Kitanaka, N. Katsumata, A. Tanae, I. Hibi, K.-I. Takeyama, H. Fuse, S. Kato, and T. Tanaka
A New Compound Heterozygous Mutation in the 11{beta}-Hydroxysteroid Dehydrogenase Type 2 Gene in a Case of Apparent Mineralocorticoid Excess
J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4054 - 4058.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. Sun, K. Yang, and J. R. G. Challis
Differential Regulation of 11 {beta}-Hydroxysteroid Dehydrogenase Type 1 and 2 by Nitric Oxide in Cultured Human Placental Trophoblast and Chorionic Cell Preparation
Endocrinology, November 1, 1997; 138(11): 4912 - 4920.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Diederich, B. Hanke, W. Oelkers, and V. Bahr
Metabolism of Dexamethasone in the Human Kidney: Nicotinamide Adenine Dinucleotide-Dependent 11{beta}-Reduction
J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1598 - 1602.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Shimojo, M. L. Ricketts, M. D. Petrelli, P. Moradi, G. D. Johnson, A. R. Bradwell, M. Hewison, A. J. Howie, and P. M. Stewart
Immunodetection of 11{beta}-Hydroxysteroid Dehydrogenase Type 2 in Human Mineralocorticoid Target Tissues: Evidence for Nuclear Localization
Endocrinology, March 1, 1997; 138(3): 1305 - 1311.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. Sun, K. Yang, and J. R. G. Challis
Differential Expression of 11{beta}-Hydroxysteroid Dehydrogenase Types 1 and 2 in Human Placenta and Fetal Membranes
J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 300 - 305.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
Y. Takeda, I. Miyamori, K. Iki, S. Inaba, K. Furukawa, H. Hatakeyama, T. Yoneda, and R. Takeda
Endogenous Renal 11ß-Hydroxysteroid Dehydrogenase Inhibitory Factors in Patients With Low-Renin Essential Hypertension
Hypertension, February 1, 1996; 27(2): 197 - 201.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
E. A. Walker, A. M. Clark, M. Hewison, J. P. Ride, and P. M. Stewart
Functional Expression, Characterization, and Purification of the Catalytic Domain of Human 11-beta -Hydroxysteroid Dehydrogenase Type 1
J. Biol. Chem., June 8, 2001; 276(24): 21343 - 21350.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Odermatt, P. Arnold, and F. J. Frey
The Intracellular Localization of the Mineralocorticoid Receptor Is Regulated by 11beta -Hydroxysteroid Dehydrogenase Type 2
J. Biol. Chem., July 20, 2001; 276(30): 28484 - 28492.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society